Antioxidants in Patients Treated for Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Chemotherapy Strategies for Metastatic PDAC
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
A Practical Guide to Prescribing in HF
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?